Literature DB >> 23837491

Impact of bone marrow stromal cells on Bcl-2 family members in chronic lymphocytic leukemia.

Viralkumar Patel1, Lisa S Chen, William G Wierda, Kumudha Balakrishnan, Varsha Gandhi.   

Abstract

Chronic lymphocytic leukemia (CLL) is the most common form of adult leukemia in the Western world. High levels of Bcl-2 family anti-apoptotic proteins are responsible for apoptosis resistance. Besides anti-apoptotic proteins, the microenvironment provides substantial survival signals to CLL leukemic cells. However, in-depth knowledge on the role of individual Bcl-2 family members in the context of the microenvironment is still limited. We performed a comprehensive analysis of transcripts and proteins of 18 Bcl-2 family members using an "apoptosis array microfluidic card" in primary cells before and after stromal co-cultures. Our data showed that five of six anti-apoptotic members (excluding Bcl-b), two of three pro-apoptotic members (excluding Bok) and six of nine BH3-only members were present at detectable mRNA levels in CLL cells. Importantly, stromal-mediated extended survival of CLL cells was strongly associated with elevated global transcription. Upon co-culturing with stromal cells, there was an early response of an increase in anti- (2/5) and pro-apoptotic protein (3/8) transcripts on day 1, while an increase in anti-apoptotic proteins was observed on day 3, with no significant change in pro-apoptotic proteins. Our study revealed a differential pattern of expression of both transcripts and proteins following stromal co-cultures, proposing a significance of Bcl-2 family members in the stromal microenvironment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23837491      PMCID: PMC4172382          DOI: 10.3109/10428194.2013.819573

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  46 in total

Review 1.  Bcl-2 and apoptosis in chronic lymphocytic leukemia.

Authors:  Aaron D Schimmer; Irene Munk-Pedersen; Mark D Minden; John C Reed
Journal:  Curr Treat Options Oncol       Date:  2003-06

2.  Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch".

Authors:  Neil E Kay; Tait D Shanafelt; Ann K Strege; Yean K Lee; Nancy D Bone; Azra Raza
Journal:  Leuk Res       Date:  2007-01-22       Impact factor: 3.156

3.  Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737.

Authors:  Victoria Del Gaizo Moore; Jennifer R Brown; Michael Certo; Tara M Love; Carl D Novina; Anthony Letai
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

4.  Inhibition of Bax channel-forming activity by Bcl-2.

Authors:  B Antonsson; F Conti; A Ciavatta; S Montessuit; S Lewis; I Martinou; L Bernasconi; A Bernard; J J Mermod; G Mazzei; K Maundrell; F Gambale; R Sadoul; J C Martinou
Journal:  Science       Date:  1997-07-18       Impact factor: 47.728

5.  Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane.

Authors:  Tomomi Kuwana; Mason R Mackey; Guy Perkins; Mark H Ellisman; Martin Latterich; Roger Schneiter; Douglas R Green; Donald D Newmeyer
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

6.  Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.

Authors:  Aleksandar Petlickovski; Luca Laurenti; Xiaoping Li; Sara Marietti; Patrizia Chiusolo; Simona Sica; Giuseppe Leone; Dimitar G Efremov
Journal:  Blood       Date:  2005-02-22       Impact factor: 22.113

7.  Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.

Authors:  Meike Burger; Tanja Hartmann; Myriam Krome; Justyna Rawluk; Hirokazu Tamamura; Nobutaka Fujii; Thomas J Kipps; Jan A Burger
Journal:  Blood       Date:  2005-05-19       Impact factor: 22.113

8.  Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease.

Authors:  Osamu Takeuchi; Jill Fisher; Heikyung Suh; Hisashi Harada; Barbara A Malynn; Stanley J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-29       Impact factor: 11.205

9.  Proapoptotic BID is required for myeloid homeostasis and tumor suppression.

Authors:  Sandra S Zinkel; Christy C Ong; David O Ferguson; Hiromi Iwasaki; Koichi Akashi; Roderick T Bronson; Jeffery L Kutok; Frederick W Alt; Stanley J Korsmeyer
Journal:  Genes Dev       Date:  2003-01-15       Impact factor: 11.361

10.  Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1.

Authors:  Joseph T Opferman; Anthony Letai; Caroline Beard; Mia D Sorcinelli; Christy C Ong; Stanley J Korsmeyer
Journal:  Nature       Date:  2003-12-11       Impact factor: 49.962

View more
  13 in total

1.  Expression of executioner procaspases and their activation by a procaspase-activating compound in chronic lymphocytic leukemia cells.

Authors:  Viralkumar Patel; Kumudha Balakrishnan; Michael J Keating; William G Wierda; Varsha Gandhi
Journal:  Blood       Date:  2014-12-23       Impact factor: 22.113

2.  Proteasome inhibitor carfilzomib complements ibrutinib's action in chronic lymphocytic leukemia.

Authors:  Betty Lamothe; Fabiola Cervantes-Gomez; Mariela Sivina; William G Wierda; Michael J Keating; Varsha Gandhi
Journal:  Blood       Date:  2015-01-08       Impact factor: 22.113

3.  Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199).

Authors:  V M Patel; K Balakrishnan; M Douglas; T Tibbitts; E Y Xu; J L Kutok; M Ayers; A Sarkar; R Guerrieri; W G Wierda; S O'Brien; N Jain; H M Stern; V Gandhi
Journal:  Leukemia       Date:  2016-12-26       Impact factor: 11.528

4.  Carfilzomib Triggers Cell Death in Chronic Lymphocytic Leukemia by Inducing Proapoptotic and Endoplasmic Reticulum Stress Responses.

Authors:  Betty Lamothe; William G Wierda; Michael J Keating; Varsha Gandhi
Journal:  Clin Cancer Res       Date:  2016-03-29       Impact factor: 12.531

5.  Proteomics profiling identifies induction of caveolin-1 in chronic lymphocytic leukemia cells by bone marrow stromal cells.

Authors:  Hima V Vangapandu; Huiqin Chen; William G Wierda; Michael J Keating; Anil Korkut; Varsha Gandhi
Journal:  Leuk Lymphoma       Date:  2017-10-03

6.  AMG-176, an Mcl-1 Antagonist, Shows Preclinical Efficacy in Chronic Lymphocytic Leukemia.

Authors:  Xue Yi; Aloke Sarkar; Gorkem Kismali; Burcu Aslan; Mary Ayres; LaKesla R Iles; Michael J Keating; William G Wierda; James P Long; Maria Teresa Sabrina Bertilaccio; Varsha Gandhi
Journal:  Clin Cancer Res       Date:  2020-01-14       Impact factor: 12.531

7.  CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase.

Authors:  Alessio Montresor; Lara Toffali; Antonella Rigo; Isacco Ferrarini; Fabrizio Vinante; Carlo Laudanna
Journal:  Oncotarget       Date:  2018-10-12

8.  Regulation of Mcl-1 expression in context to bone marrow stromal microenvironment in chronic lymphocytic leukemia.

Authors:  Kumudha Balakrishnan; Jan A Burger; Min Fu; Tejaswini Doifode; William G Wierda; Varsha Gandhi
Journal:  Neoplasia       Date:  2014-12       Impact factor: 5.715

9.  The Stromal Microenvironment Modulates Mitochondrial Oxidative Phosphorylation in Chronic Lymphocytic Leukemia Cells.

Authors:  Hima V Vangapandu; Mary L Ayres; Christopher A Bristow; William G Wierda; Michael J Keating; Kumudha Balakrishnan; Christine M Stellrecht; Varsha Gandhi
Journal:  Neoplasia       Date:  2017-08-30       Impact factor: 5.715

10.  Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia.

Authors:  Maurizio Mangolini; Frederik Götte; Andrew Moore; Tim Ammon; Madlen Oelsner; Gloria Lutzny-Geier; Ludger Klein-Hitpass; James C Williamson; Paul J Lehner; Jan Dürig; Michael Möllmann; Lívia Rásó-Barnett; Katherine Hughes; Antonella Santoro; Simón Méndez-Ferrer; Robert A J Oostendorp; Ursula Zimber-Strobl; Christian Peschel; Daniel J Hodson; Marc Schmidt-Supprian; Ingo Ringshausen
Journal:  Nat Commun       Date:  2018-09-21       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.